MAK Capital Fund LP·SCHEDULE 13G

Mar 4, 4:40 PM ET

Protalix BioTherapeutics, Inc. SCHEDULE 13G

SCHEDULE 13G · MAK Capital Fund LP · Filed Mar 4, 2026

Documents

2 files